These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28236795)

  • 21. Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: brief communication.
    Abdulnour HA; Araya CE; Dharnidharka VR
    Pediatr Transplant; 2010 Dec; 14(8):1007-11. PubMed ID: 20819180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients - an Observational Study in Germany.
    Lehner LJ; Kalb K; Weigand K; Pein U; Schenker P; Seeger W; Roehle R; Dienes K; Halleck F; Budde K
    Curr Rev Clin Exp Pharmacol; 2021; 16(4):357-368. PubMed ID: 33588739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Special considerations in generic substitution of immunosuppressive drugs in transplantation].
    Remport A; Dankó D; Gerlei Z; Czebe K; Kiss I
    Orv Hetil; 2012 Aug; 153(34):1341-9. PubMed ID: 22913916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan and Mowel after liver transplantation.
    Vollmar J; Bellmann MC; Darstein F; Hoppe-Lotichius M; Mittler J; Heise M; Rüttger B; Weyer V; Zimmermann A; Lang H; Galle PR; Zimmermann T
    Drug Des Devel Ther; 2015; 9():6139-49. PubMed ID: 26604701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.
    Dannhorn E; Cheung M; Rodrigues S; Cooper H; Thorburn D; Patch D; Burroughs AK; O'Beirne J
    Clin Transplant; 2014 Dec; 28(12):1349-57. PubMed ID: 25142496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
    Uemoto S; Abe R; Horike H; So M
    Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
    Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
    Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients.
    Wu MJ; Cheng CY; Chen CH; Wu WP; Cheng CH; Yu DM; Chuang YW; Shu KH
    Transplantation; 2011 Sep; 92(6):648-52. PubMed ID: 21912349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limustin®, a non-innovator tacrolimus formulation, yields reduced drug exposure in pediatric renal transplant recipients.
    Jacobo-Cabral CO; García-Roca P; Reyes H; Lozada-Rojas L; Cruz-Antonio L; Medeiros M; Castañeda-Hernandez G
    Pediatr Transplant; 2014 Nov; 18(7):706-13. PubMed ID: 25156476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients.
    Notaro E; Brown L; Albers E; Law S; Kemna M
    J Heart Lung Transplant; 2014 Jul; 33(7):766-8. PubMed ID: 24854566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.